214 related articles for article (PubMed ID: 26656342)
1. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Li MX; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Zhao H; Cai JQ
Medicine (Baltimore); 2015 Dec; 94(49):e2133. PubMed ID: 26656342
[TBL] [Abstract][Full Text] [Related]
2. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
[TBL] [Abstract][Full Text] [Related]
3. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Xu L; Wu J; Lu W; Yang C; Liu H
Transplant Proc; 2019 Dec; 51(10):3338-3346. PubMed ID: 31732203
[TBL] [Abstract][Full Text] [Related]
4. The Glasgow Prognostic Score is an independent prognostic predictor of hepatocellular carcinoma following radical resection.
Pan QX; Zhang JH; Su ZJ; Wang CR; Ke SY
Oncol Res Treat; 2014; 37(4):192-7. PubMed ID: 24732643
[TBL] [Abstract][Full Text] [Related]
5. ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review.
Peng Y; Wei Q; He Y; Xie Q; Liang Y; Zhang L; Xia Y; Li Y; Chen W; Zhao J; Chai J
Expert Rev Gastroenterol Hepatol; 2020 May; 14(5):383-400. PubMed ID: 32240595
[TBL] [Abstract][Full Text] [Related]
6. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
7. The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M; Saeki C; Tajiri H
BMC Cancer; 2013 Feb; 13():52. PubMed ID: 23374755
[TBL] [Abstract][Full Text] [Related]
8. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
9. Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Zhang X; Xin Y; Chen Y; Zhou X
Sci Rep; 2023 Jan; 13(1):1808. PubMed ID: 36720974
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis.
Peng X; Huang Y; Zhang M; Chen Y; Zhang L; He A; Luo R
Dis Markers; 2022; 2022():3533714. PubMed ID: 35186165
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Pang Q; Qu K; Zhang JY; Song SD; Liu SS; Tai MH; Liu HC; Liu C
Medicine (Baltimore); 2015 Sep; 94(37):e1431. PubMed ID: 26376382
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.
Schoenleber SJ; Kurtz DM; Talwalkar JA; Roberts LR; Gores GJ
Br J Cancer; 2009 May; 100(9):1385-92. PubMed ID: 19401698
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of C-reactive protein to albumin ratio in patients with hepatocellular carcinoma: A meta-analysis.
Fan Y; Gu X; Gao Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):241-243. PubMed ID: 31444039
[No Abstract] [Full Text] [Related]
15. New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
Tada T; Kumada T; Hiraoka A; Kariyama K; Tani J; Hirooka M; Takaguchi K; Atsukawa M; Fukunishi S; Itobayashi E; Tsuji K; Tajiri K; Ochi H; Ishikawa T; Yasuda S; Ogawa C; Toyoda H; Hatanaka T; Nishimura T; Kakizaki S; Kawata K; Shimada N; Tada F; Nouso K; Tsutsui A; Ohama H; Morishita A; Nagano T; Itokawa N; Okubo T; Arai T; Kosaka H; Imai M; Naganuma A; Nakamura S; Koizumi Y; Kaibori M; Iijima H; Hiasa Y;
Cancer Med; 2023 Mar; 12(6):6980-6993. PubMed ID: 36484470
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
17. Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysis.
Tada T; Kumada T; Hiraoka A; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Naganuma A; Aoki T; Koizumi Y; Nakamura S; Joko K; Hiasa Y; Kudo M;
Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):857-864. PubMed ID: 35802527
[TBL] [Abstract][Full Text] [Related]
18. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
Nie D; Zhang L; Wang C; Guo Q; Mao X
Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
[TBL] [Abstract][Full Text] [Related]
20. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.
Xu ZG; Ye CJ; Liu LX; Wu G; Zhao ZX; Wang YZ; Shi BQ; Wang YH
Biomark Med; 2018 Feb; 12(2):189-199. PubMed ID: 29327595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
